Literature DB >> 9004438

Isotype-specific antibody responses to rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SA11 rotavirus core-like particles (CLP) or virus-like particles (VLP).

F M Fernandez1, M E Conner, A V Parwani, D Todhunter, K L Smith, S E Crawford, M K Estes, L J Saif.   

Abstract

The isotype antibody responses to bovine IND P5, G6 and simian SA11 P2, G3 rotavirus and SA11 rotavirus proteins (VP4, VP6 and VP7) in serum, colostrum and milk were analysed by ELISA in three groups of vaccinated cows and nonvaccinated controls. Pregnant cows were vaccinated intramuscularly and intramammarily with recombinant baculovirus-expressed SA11 rotavirus VLP (triple-layered virus-like particles containing rotavirus VP2, VP4, VP6 and VP7); CLP (double-layered core-like particles containing rotavirus VP2 and VP6); or inactivated SA11 rotavirus, respectively. Rotavirus antigen titers were highest (30-200-fold) in ELISA in the VLP vaccine compared to the inactivated SA11 vaccine. The IgG1, IgG2 and IgM geometric mean antibody titers (GMT) to rotavirus (titers to bovine rotavirus vs SA11 rotavirus did not differ significantly for any isotype or group) and the IgG2 GMT to VP6 in serum at calving in the vaccinated groups were significantly (P < 0.05) higher than in the control group. In colostrum, IgG1 and IgA rotavirus antibody titers were significantly elevated for VLP (IgG1 GMT 832225; IgA GMT 16384), CLP (IgG1 GMT 660561; IgA GMT 10321) and SA11 (IgG1 GMT 131072; IgA GMT 1448) vaccinated cows compared to control cows (IgG1 GMT 11585; IgA GMT 45). The IgG1 and IgA GMT to rotavirus were significantly elevated (6-100-fold) in milk of VLP and CLP vaccinated cows compared to SA11 vaccinated or control cows. The isotype antibody responses to VP6 in serum, colostrum and milk paralleled the responses to rotavirus, but titers were approximately 2-10-fold lower. Only cows vaccinated with VLP had significantly enhanced serum, colostral and milk antibody titers to rotavirus VP4 and VP7. These results demonstrate that rotavirus antibody titers in serum, colostrum and milk are significantly enhanced by use of non-infectious VLP, CLP and inactivated SA11 rotavirus vaccines, but the VLP or CLP vaccines induced the highest antibody responses, corresponding to their higher rotavirus antigen titers measured by ELISA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9004438      PMCID: PMC7131174          DOI: 10.1016/s0264-410x(96)00065-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  28 in total

1.  Protective efficacy of virus-like particles for bluetongue disease.

Authors:  P Roy; T French; B J Erasmus
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells.

Authors:  S E Crawford; M Labbé; J Cohen; M H Burroughs; Y J Zhou; M K Estes
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

Review 3.  Rotaviruses.

Authors:  M S McNulty
Journal:  J Gen Virol       Date:  1978-07       Impact factor: 3.891

4.  Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus.

Authors:  M K Ijaz; S K Attah-Poku; M J Redmond; M D Parker; M I Sabara; P Frenchick; L A Babiuk
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.

Authors:  M J Redmond; M K Ijaz; M D Parker; M I Sabara; D Dent; E Gibbons; L A Babiuk
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

6.  Cross-neutralizing antibodies induced by single serotype vaccination of cows with rotavirus.

Authors:  H Brüssow; I Walther; V Fryder; J Sidoti; A Bruttin
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

7.  Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized or nonimmunized cows.

Authors:  L J Saif; D R Redman; K L Smith; K W Theil
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Passive protection of newborn calves against rotavirus by vaccination of their dams.

Authors:  M Dauvergne; A Brun; J P Soulebot
Journal:  Dev Biol Stand       Date:  1983

9.  Antigenic mapping of the surface proteins of rhesus rotavirus.

Authors:  R D Shaw; P T Vo; P A Offit; B S Coulson; H B Greenberg
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

10.  Efficacy of an inactivated oil-adjuvanted rotavirus vaccine in the control of calf diarrhoea in beef herds in Argentina.

Authors:  R C Bellinzoni; J Blackhall; N Baro; N Auza; N Mattion; A Casaro; J L La Torre; E A Scodeller
Journal:  Vaccine       Date:  1989-06       Impact factor: 3.641

View more
  9 in total

1.  Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus.

Authors:  L Yuan; S Y Kang; L A Ward; T L To; L J Saif
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

2.  An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic pig model.

Authors:  Marli S P Azevedo; Ana Maria Gonzalez; Lijuan Yuan; Kwang-Il Jeong; Cristiana Iosef; Trang Van Nguyen; Karin Lovgren-Bengtsson; Bror Morein; Linda J Saif
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

3.  Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.

Authors:  L Yuan; C Iosef; M S Azevedo; Y Kim; Y Qian; A Geyer; T V Nguyen; K O Chang; L J Saif
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 4.  Enteric viral infections of pigs and strategies for induction of mucosal immunity.

Authors:  L J Saif
Journal:  Adv Vet Med       Date:  1999

5.  Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines.

Authors:  F M Fernandez; M E Conner; D C Hodgins; A V Parwani; P R Nielsen; S E Crawford; M K Estes; L J Saif
Journal:  Vaccine       Date:  1998-03       Impact factor: 3.641

6.  Influence of individual or group housing of newborn calves on rotavirus and coronavirus infection during the first 2 months of life.

Authors:  E A Bertoni; M Bok; C Vega; G M Martinez; R Cimino; V Parreño
Journal:  Trop Anim Health Prod       Date:  2021-01-03       Impact factor: 1.559

7.  Efficacy of prepartum vaccination against neonatal calf diarrhea in Nelore dams as a prevention measure.

Authors:  Filipe Aguera Pinheiro; Nathália Decaris; Viviana Parreño; Paulo Eduardo Brandão; Henderson Ayres; Viviani Gomes
Journal:  BMC Vet Res       Date:  2022-08-22       Impact factor: 2.792

Review 8.  Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model.

Authors:  Lijuan Yuan; Linda J Saif
Journal:  Vet Immunol Immunopathol       Date:  2002-09-10       Impact factor: 2.046

9.  Modulation by colostrum-acquired maternal antibodies of systemic and mucosal antibody responses to rotavirus in calves experimentally challenged with bovine rotavirus.

Authors:  V Parreño; C Béjar; A Vagnozzi; M Barrandeguy; V Costantini; M I Craig; L Yuan; D Hodgins; L Saif; F Fernández
Journal:  Vet Immunol Immunopathol       Date:  2004-07       Impact factor: 2.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.